Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of recurrent BRAF non-V600 mutations in intraductal carcinoma of the prostate in Chinese populations.

Neoplasia (New York, N.Y.) - 1 Apr 2024

Hu Jing, Chen Xinyi, Sun Feifei, Liu Lili, Liu Long, Yang Zimeng, Zhang Hanwen, Yu Zeyuan, Zhao Ru, Wang Yueyao, Liu Hui, Yang Xiaorong, Sun Fusheng, Han Bo

Abstract excerpt

While BRAF alterations have been established as a driver in various solid malignancies, the characterization of BRAF alterations in prostate cancer (PCa) has not been thoroughly interrogated. By bioinformatics analysis, we first found that BRAF alterations were associated with advanced PCa and exhibited mutually exclusive pattern with ERG alteration across multiple cohorts. Of the most interest, recurrent...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Intraductal, Noninfiltrating
Share to China

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Mutation

Share to Prostate

Share to Prostatic Neoplasms

Share to Proto-Oncogene Proteins B-raf

Source

Open in PubMed Open full text

Identifiers

PMID: 38417222
DOI: 10.1016/j.neo.2024.100983
PMCID: PMC10904907

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of recurrent BRAF non-V600 mutations in intraductal carcinoma of the prostate in Chinese populations.PMID 38417222Read ↗

Unique Spectrum of Activating BRAF Alterations in Prostate Cancer.Semantic proximity Read ↗

Genomic Features and Clinical Implications of Intraductal Carcinoma of the Prostate.Semantic proximity Read ↗

MEK inhibitor sensitivity in BRAF fusion-driven prostate cancer.Semantic proximity Read ↗

Prospective clinical sequencing of 1016 Chinese prostate cancer patients: uncovering genomic characterization and race disparity.Semantic proximity Read ↗

Metastatic prostate cancer is associated with distinct higher frequency of genetic mutations at diagnosis.Semantic proximity Read ↗

Spectrum of BRAF Aberrations and Its Potential Clinical Implications: Insights From Integrative Pan-Cancer AnalysisSemantic proximity Read ↗

Integrative analysis of cancer driver genes in prostate adenocarcinomaSemantic proximity Read ↗

Intratumoral heterogeneity and genetic characteristics of prostate cancer.Semantic proximity Read ↗

Identification of frequent BRAF copy number gain and alterations of RAF genes in chinese prostate cancerSemantic proximity Read ↗

Molecular evaluation of BRAF V600 mutation and its association with clinicopathological characteristics: First findings from Indian malignant melanoma patientsSemantic proximity Read ↗

Molecular classification of prostate adenocarcinoma by the integrated somatic mutation profiles and molecular network.Semantic proximity Read ↗

PIN-like ductal carcinoma of the prostate has frequent activating RAS/RAF mutations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.